- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial
- Study type descriptors: Interventional
- Study aim: To assess the feasibility of recruiting and retaining patients with Post-COVID in a primary care setting and to investigate the effectiveness and safety of prednisolone and/or vitamin B1/6/12
- Number of participants enrolled: 321
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults
- Elderly
- General population
- Primary care
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Immnunomodulator
- Prednisolone
- Vitamin B1
- Vitamin B6
- Vitamin B12
External Links
Other information
Funders:
- Wuerzburg University Hospital
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to